TLPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TLPH is not a good buy right now for an impatient investor. Despite being deeply oversold (RSI-6 ~19) and showing heavy insider buying, price momentum is still bearish (MACD histogram negative and expanding) and the statistical pattern outlook also leans lower over the next day/week/month. This sets up as a potential “dead-cat bounce” candidate near support, not a high-confidence immediate entry.
Trend/Momentum: Bearish near-term. MACD histogram (-0.00208) is below zero and negatively expanding, signaling strengthening downside momentum. Overbought/Oversold: RSI(6) at ~19.18 is extremely oversold, which can produce short bounces but is not a reversal signal by itself. Levels: Pivot 0.988 is the key reclaim level; price (post-market ~0.9566) is below it. Immediate support S1 ~0.946 (very close) then S2 ~0.92. Resistance zones: R1 ~1.03 then R2 ~1.056. Interpretation: The setup is oversold-at-support, but still in a falling tape. A more convincing buy would require stabilization above ~0.988 and ideally a momentum shift (MACD flattening/turning).
Intellectia Proprietary Trading Signals
Quant pattern read-through: Similar-pattern stats imply ~60% chance of further downside (about -1.34% next day, -2.05% next week, -6.29% next month), aligning with the bearish momentum signals.
near first support (~0.
can fuel a short-term bounce if selling pressure exhausts.
Momentum remains bearish (MACD negative and expanding) and price is below the pivot (0.988), implying the path of least resistance is still down.
No supportive news flow in the last week; no clear near-term external catalyst to reverse trend.
Company remains unprofitable; options imply very large expected moves (high absolute IV), which often accompanies unstable price action.
Similar-pattern probability skew points to further downside over the next day/week/month.
Latest quarter: 2025/Q3. Revenue: 1,000, flat YoY (0.00%), indicating no meaningful top-line growth. Net income: -4.436M, improved ~32.30% YoY (loss narrowed), which is directionally positive. EPS: -0.11, down ~15.38% YoY (worse per-share loss), a negative on a per-share basis. Overall: Some improvement in net loss, but fundamentals still show minimal revenue and ongoing losses—more speculative than fundamentally strengthening.
No analyst rating or price target change data was provided, so a current Wall Street consensus trend cannot be confirmed from the dataset. Practically, the visible ‘pros’ case rests on insider buying and oversold technicals; the ‘cons’ case is persistent bearish momentum and lack of demonstrated revenue growth/profitability.
